- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03550079
Fixation for the Treatment of Femoral Neck Fractures
June 11, 2018 updated by: Hebei Medical University Third Hospital
the Fixation Method for the Treatment of Femoral Neck Fractures
The femoral neck fracture is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma .
Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family.
The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible.
However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other .
Study Overview
Detailed Description
The incidence of femoral neck fracture accounts for 3.6% of all fractures, is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma .
Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family.
The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible.
However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other depending on the extent of displacement, fracture configuration, physiological age of the patient, bone quality or other relative factors.
Nonoperative management is considered only when patients are seriously ill or presented with excessive surgical risk.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050000
- Recruiting
- The Third Hospital of Hebei Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- closed femoral neck fracture
- no fractures at other sites
- surgical treatment with cannulated compression screws or PFNA
- follow-up time greater than 1 years.
Exclusion Criteria:
- the absence of severe cognitive dysfunction,
- the presence of a pathological femoral neck fracture
- previous femoral neck fracture, treated with other internal fixations and surgical treatment with open reduction.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: three screws fixation
femoral neck fractures were fixed with three converted screws
|
treated with different fixation method
|
|
Experimental: four screws fixation
femoral neck fractures were fixed with four screws
|
treated with different fixation method
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
outcome measure were evaluated by femoral neck shortening with X rays
Time Frame: up to 12 months
|
femoral neck shortening after 1 year with radiology measure,
|
up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
nonunion
Time Frame: up to 12 months
|
the number of nonunion at the end of follow up in patients
|
up to 12 months
|
|
screw-exit
Time Frame: up to 12 months
|
screw-exit afer 1 year with X rays in all patients
|
up to 12 months
|
|
cut-out
Time Frame: up t 12 months
|
cut-out of the screw evaluating with x rays in all patients
|
up t 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operative time in every patient
Time Frame: intraoperation
|
outcome measure were evaluated by operative time
|
intraoperation
|
|
fluoroscopy time intraoperatively
Time Frame: intraoperation
|
outcome measure were evaluated by operative time and fluroscopy time
|
intraoperation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: zhiyong Hou, MD, Hebei Medical University Third Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2017
Primary Completion (Anticipated)
December 30, 2018
Study Completion (Anticipated)
December 30, 2018
Study Registration Dates
First Submitted
April 23, 2018
First Submitted That Met QC Criteria
May 25, 2018
First Posted (Actual)
June 8, 2018
Study Record Updates
Last Update Posted (Actual)
June 13, 2018
Last Update Submitted That Met QC Criteria
June 11, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11156458
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
the data should be allowed by Zhang Yingze
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.